Department of Molecular Biology, Washington Road, LTL 255, Princeton University, Princeton, New Jersey 08544, USA.
Nat Rev Cancer. 2011 Sep 23;11(10):735-48. doi: 10.1038/nrc3125.
Despite recognizing the devastating consequences of metastasis, we are not yet able to effectively treat cancer that has spread to vital organs. The inherent complexity of genomic alterations in late-stage cancers, coupled with numerous heterotypic interactions that occur between tumour and stromal cells, represent fundamental challenges in our quest to understand and control metastatic disease. The incorporation of genomic and other systems level approaches, as well as technological breakthroughs in imaging and animal modelling, have galvanized the effort to overcome gaps in our understanding of metastasis. Future research carries with it the potential to translate the wealth of new knowledge and conceptual advances into effective targeted therapies.
尽管我们已经认识到转移的破坏性后果,但仍无法有效治疗已经扩散到重要器官的癌症。晚期癌症中基因组改变的固有复杂性,加上肿瘤细胞和基质细胞之间发生的众多异质相互作用,是我们理解和控制转移性疾病的基本挑战。基因组和其他系统水平方法的结合,以及成像和动物模型方面的技术突破,激发了我们努力克服对转移认识不足的差距。未来的研究有可能将大量新知识和概念进展转化为有效的靶向治疗。